1. Preface

   • U. K. Rinne

   EditorialNotes Pages: 1 - 1

2. Characterization of normal and supersensitive dopamine receptors: Effects of ergot drugs and neuropeptides

   • K. Fuxe
   • L. F. Agnati
   • T. Hökfelt

   OriginalPaper Pages: 3 - 37

3. Neurochemical effects of some ergot derivatives: A basis for their antiparkinson actions

   • R. Markstein

   OriginalPaper Pages: 39 - 59

4. The endocrine profile of bromocriptine: Its application in endocrine diseases

   • Ioana Lancranjan

   OriginalPaper Pages: 61 - 82

5. Neuropeptides in striato-nigral pathways

   • A. C. Cuello
   • M. Del Fiacco
   • J. V. Priestley

   OriginalPaper Pages: 83 - 96

6. Dopamine receptors in the parkinsonian brain

   • U. K. Rinne
   • P. Lönnberg
   • V. Koskinen

   OriginalPaper Pages: 97 - 106

7. The effects of lisuride and some other dopaminergic agonists on receptor binding in human brain

   • G. P. Reynolds
   • P. Riederer

   OriginalPaper Pages: 107 - 111

8. Transitional states of central serotonin receptors in Parkinson's disease

   • E. Kienzl
   • P. Riederer
   • W. Wesemann

   OriginalPaper Pages: 113 - 122

9. Prolactin response as an index of dopaminergic receptor function in Parkinson's disease. Correlation with clinical findings and therapeutic response

   • A. Agnoli
   • M. Baldassarre
   • A. Rocco

   OriginalPaper Pages: 123 - 134

10. Epidemiology of Parkinson's disease—An overview

    • R. J. Marttila
    • U. K. Rinne

    OriginalPaper Pages: 135 - 148

11. Assessment of hypokinesia in parkinsonism

    • H. Teräväinen
    • D. B. Calne

    OriginalPaper Pages: 149 - 159

12. Treatment of Parkinson's disease: Problems with a progressing disease

    • U. K. Rinne

    OriginalPaper Pages: 161 - 174

13. Recent advances in the treatment of Parkinson's disease: The role of bromocriptine

    • P. A. Le Witt
    • D. B. Calne

    OriginalPaper Pages: 175 - 184